The fund outperformed its benchmark with a 1.66% return for the quarter ending September 30, 2025. Click here for more on ...

The year 2025 has not been a great one for U.S.-Chinese relations. Tit-for-tat tariffs and the scramble over rare earth ...

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD) (OTCQB: DVHGF), today announced operating and financial ...

Quality assurance body Umalusi has thrown its weight behind the Department of Basic Education’s ongoing investigation into ...

Columbia Bond Fund navigated Q3 2025, returning 1.91% amid resilient markets and Fed rate cuts. Read the full report now to ...

Ondo state governor, Lucky Aiyedatiwa, has declared that the state has reached a defining moment in its economic journey, affirming that the state is now fully ready for global investment, large-scale ...

VANCOUVER, BC / ACCESS Newswire / December 11, 2025 / LIR Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company") announces that it has filed a provisional patent ...

Continued Growth of the Business with Q3 Ending Active Subscribers +12.4% YoY; Revenue up 15.4% YOYClosed Transformative Recapitalization Plan, ...

Education & Technology Group Inc. (NASDAQ: YQ) ('17EdTech” or the 'Company”), a leading education technology company in China ...

VANCOUVER, BC / ACCESS Newswire / December 11, 2025 / LIR Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company") announces that it has filed a provisional patent applicat ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the presentation of preclinical ...